| Name: | Apremilast Impurity 1 |
| Catalogue No. | VE008007 |
| CAS No. | 608141-43-1 |
| Molecular Formula | C12H19NO4S ; C8H15NO3 |
| Molecular Weight | 273.4 ; 173.2 g/mol |
| Status | In-Stock |
| IUPAC Name | (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine acetyl-L-leucinate |
| Description | Apremilast Impurity 1 (CAS NO.-608141-43-1) IUPAC Name-(S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine acetyl-L-leucinate. Apremilast is an oral phosphodiesterase 4 inhibitor that have an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is a novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals. |
| References | Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001. |
